148 related articles for article (PubMed ID: 35116300)
1. Efficiency of C-reactive protein in prognosis evaluation of prostate cancer: a systematic review and meta-analysis.
Du J; Lan J; Xiong J; Yang H; Xu X; Tang C; Huang G; Ying Q; Mu J; Hu Q
Transl Cancer Res; 2021 Oct; 10(10):4432-4439. PubMed ID: 35116300
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
[TBL] [Abstract][Full Text] [Related]
3. C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
Liao DW; Hu X; Wang Y; Yang ZQ; Li X
Ann Clin Lab Sci; 2020 Mar; 50(2):161-171. PubMed ID: 32366552
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
7. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Fang JM; Xiao YY; Zhao Y; Cui R; Hu F; Xu Q
Int J Clin Exp Med; 2015; 8(2):2289-98. PubMed ID: 25932165
[TBL] [Abstract][Full Text] [Related]
12. The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Han CL; Meng GX; Ding ZN; Dong ZR; Chen ZQ; Hong JG; Yan LJ; Liu H; Tian BW; Yang LS; Xue JS; Li T
Front Immunol; 2022; 13():827788. PubMed ID: 35211122
[TBL] [Abstract][Full Text] [Related]
13. Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.
Luo Y; Fu SJ; She DL; Xiong HU; Yang LI
Mol Clin Oncol; 2015 Jul; 3(4):924-928. PubMed ID: 26171208
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis.
Li D; Lv H; Hao X; Hu B; Song Y
Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value of Plasma Cell-Free DNA Concentration in the Prostate Cancer: A Systematic Review and Meta-Analysis.
Liu H; Gao Y; Vafaei S; Gu X; Zhong X
Front Oncol; 2021; 11():599602. PubMed ID: 33777743
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
18. The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy.
Knittelfelder O; Delago D; Jakse G; Lukasiak K; Thurner EM; Thurnher D; Pichler M; Renner W; Stranzl-Lawatsch H; Langsenlehner T
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182693
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
